↓ Skip to main content

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, October 2003
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
131 Dimensions

Readers on

mendeley
68 Mendeley
Title
The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review
Published in
Journal of Cancer Research and Clinical Oncology, October 2003
DOI 10.1007/s00432-003-0498-7
Pubmed ID
Authors

S. M. Swain, P. Vici

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Chile 1 1%
Portugal 1 1%
Brazil 1 1%
Unknown 63 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 15%
Researcher 10 15%
Student > Master 10 15%
Student > Postgraduate 8 12%
Other 7 10%
Other 13 19%
Unknown 10 15%
Readers by discipline Count As %
Medicine and Dentistry 24 35%
Biochemistry, Genetics and Molecular Biology 12 18%
Agricultural and Biological Sciences 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Nursing and Health Professions 1 1%
Other 6 9%
Unknown 15 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2020.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#660
of 2,828 outputs
Outputs of similar age
#19,992
of 56,847 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#3
of 8 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,828 research outputs from this source. They receive a mean Attention Score of 3.8. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 56,847 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.